Alerts will be sent to your verified email
Verify Email
KGVL
|
Khyati Global Vent
|
Fortune Intl
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
21.66 % | 24.63 % | -2.16 % |
|
5yr average Equity Multiplier
|
4.13 | 1.08 | 1.43 |
|
5yr Average Asset Turnover Ratio
|
2.42 | 0.04 | 1.33 |
|
5yr Avg Net Profit Margin
|
2.47 % | 121.76 % | 0.06 % |
|
Price to Book
|
1.47 | 0.97 | 23.37 |
|
P/E
|
9.42 | 13.2 | 31.83 |
|
5yr Avg Cash Conversion Cycle
|
69.88 Days | 0.0 | 362.19 Days |
|
Inventory Days
|
16.42 Days | 0.0 | 0.0 |
|
Days Receivable
|
90.09 Days | 0.0 | 362.19 Days |
|
Days Payable
|
39.35 Days | 65.92 Days | 18.78 Days |
|
5yr Average Interest Coverage Ratio
|
3.12 | -236.75 | -272.71 |
|
5yr Avg ROCE
|
35.0 % | 3.63 % | -0.79 % |
|
5yr Avg Operating Profit Margin
|
2.69 % | 33.56 % | 1.78 % |
|
5 yr average Debt to Equity
|
1.95 | 0.08 | 0.06 |
|
5yr CAGR Net Profit
|
30.08 % | -17.93 % | 24.57 % |
|
5yr Average Return on Assets
|
5.64 % | 21.48 % | -1.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.86 % | 62.17 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 7.81 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Khyati Global Vent
|
Fortune Intl
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|